Kuhnz W, Pfeffer M, al-Yacoub G
Research Laboratories, Schering AG, Berlin, F.R.G.
J Steroid Biochem. 1990 Feb;35(2):313-8. doi: 10.1016/0022-4731(90)90290-9.
The protein binding of ethinylestradiol (EE2), gestodene (GEST) and 3-keto-desogestrel (KDG) has been determined by ultrafiltration in the serum of women who had either taken a gestodene (n = 37) or desogestrel (n = 28) containing oral contraceptive for a time period of at least 3 months. GEST and KDG were analyzed in individual serum pools whereas EE2 was repeatedly measured in two serum pools, each one representing one treatment group. The respective free fractions of the three steroids were 0.6 +/- 0.1% (GEST), 2.5 +/- 0.2% (KDG), 1.7 +/- 0.6% (EE2, in the gestodene-group) and 1.5 +/- 0.2% (EE2, in the desogestrel-group). EE2 was exclusively bound to albumin, whereas GEST and KDG were also bound to sex-hormone-binding globulin (SHBG). The distribution of the two progestins over the serum binding proteins was determined after heat-treatment of serum samples. For GEST, the contribution of albumin and SHBG was 24.1 +/- 9.1 and 75.3 +/- 9.1%, respectively and for KDG it was 65.9 +/- 11.9 and 31.6 +/- 12.0%, respectively. SHBG and corticosteroid-binding globulin (CBG) concentrations were measured in the serum samples obtained from both treatment groups. In the gestodene-group 180 +/- 61 nmol/l (SHBG) and 89 +/- 13 mg/l (CBG) were measured, the corresponding values in the desogestrel-group were 226 +/- 64 nmol/l (SHBG) and 93 +/- 14 mg/l (CBG). SHBG concentrations were correlated with the total concentration of GEST and its free fraction and a positive (r = 0.395) and negative (r = -0.491) correlation respectively was found. Only a weak negative correlation (r = -0.291) was found for SHBG and the free fraction of KDG in the serum. These data demonstrate that the three contraceptive steroids EE2, GEST and KDG were all bound extensively to serum proteins, however, with pronounced differences concerning their distribution over the various binding proteins.
通过超滤法测定了炔雌醇(EE2)、孕二烯酮(GEST)和3-酮去氧孕烯(KDG)在服用含孕二烯酮(n = 37)或去氧孕烯(n = 28)口服避孕药至少3个月的女性血清中的蛋白结合率。对个体血清池进行了GEST和KDG分析,而对两个血清池反复测定了EE2,每个血清池代表一个治疗组。三种甾体激素各自的游离分数分别为0.6±0.1%(GEST)、2.5±0.2%(KDG)、1.7±0.6%(孕二烯酮组中的EE2)和1.5±0.2%(去氧孕烯组中的EE2)。EE2仅与白蛋白结合,而GEST和KDG也与性激素结合球蛋白(SHBG)结合。血清样品经热处理后,测定了两种孕激素在血清结合蛋白上的分布情况。对于GEST,白蛋白和SHBG的贡献率分别为24.1±9.1%和75.3±9.1%,对于KDG,其贡献率分别为65.9±11.9%和31.6±12.0%。在两个治疗组获得的血清样品中测定了SHBG和皮质类固醇结合球蛋白(CBG)的浓度。孕二烯酮组测得SHBG为180±61 nmol/l,CBG为89±13 mg/l,去氧孕烯组的相应值分别为226±64 nmol/l(SHBG)和93±14 mg/l(CBG)。SHBG浓度与GEST的总浓度及其游离分数相关,分别发现呈正相关(r = 0.395)和负相关(r = -0.491)。血清中SHBG与KDG的游离分数之间仅发现弱负相关(r = -0.291)。这些数据表明,三种避孕甾体激素EE2、GEST和KDG均与血清蛋白广泛结合,然而,它们在各种结合蛋白上的分布存在显著差异。